Open AccessNonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare
Author(s) -
Gabrielle Ritaccio,
Gianna Stoleru,
Ameer Abutaleb,
Raymond K. Cross,
Kirti Shetty,
Sasan Sakiani,
Uni Wong
Publication year - 2020
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-020-06588-6
Subject(s) - nonalcoholic fatty liver disease , medicine , gastroenterology , hepatology , steatosis , fatty liver , fibrosis , inflammatory bowel disease , liver disease , disease
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in western countries and an increasing cause of end-stage liver disease and hepatocellular carcinoma. NAFLD is known to coexist in patients with inflammatory bowel disease (IBD). This study aims to examine the prevalence of NAFLD, as well as trends in NAFLD-associated fibrosis, in a well-characterized IBD cohort utilizing a validated noninvasive test.